Research Article

Spike Protein Subunits of SARS-CoV-2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa

Figure 4

Cytochrome C oxidase (a) and lactate dehydrogenase (b) activities in HPMEC incubated under control condition and in the presence of LPS (1 μg/mL) with and without recombinant COVID-19 spike S1 and S2 subunits (10 nmol/L, each subunit) (LPS+S1+S2 subunits). The effect of rivaroxaban (50 nmol/L) on LPS-incubated HPMEC with COVID-19 spike S1 and S2 subunits was also examined. Results are represented as of four experiments. respect to control. #With respect to LPS alone. & respect to LPS+S1+S2 subunits.
(a)
(b)